Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 1/20 | 0.57 |
| ▸ | MAOB | P27338 | 1/20 | 0.57 |
| ▸ | AHR | P35869 | 2/20 | 0.55 |
| ▸ | NPC1 | O15118 | 5/20 | 0.53 |
| ▸ | RAB9A | P51151 | 5/20 | 0.53 |
| ▸ | MEN1 | O00255 | 3/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.53 |
| ▸ | RXFP1 | Q9HBX9 | 3/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | SMYD3 | Q9H7B4 | 1/20 | 0.51 |
| ▸ | EGFR | P00533 | 2/20 | 0.49 |
| ▸ | PIK3CA | P42336 | 2/20 | 0.49 |
| ▸ | AR | P10275 | 1/20 | 0.48 |
| ▸ | CBR1 | P16152 | 1/20 | 0.48 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.48 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6168742 | 0.89 | NPC1 (0.66) | MAOAMAOBNPC1RAB9ALMNA | |
| SCHEMBL30395353 | 0.89 | NPC1 (0.66) | MAOAMAOBNPC1RAB9ALMNA | |
| SCHEMBL486475 | 0.88 | MAOB (0.56) | MAOBNPC1RAB9AMEN1KMT2A | |
| SCHEMBL16627875 | 0.86 | ADORA3 (0.53) | NPC1RAB9AMEN1KMT2ARXFP1 | |
| SCHEMBL34468802 | 0.86 | MEN1 (0.54) | NPC1RAB9AMEN1KMT2ARXFP1 | |
| SCHEMBL21639712 | 0.85 | MAOA (0.58) | MAOAMAOBNPC1RAB9AMEN1 | |
| SCHEMBL16627766 | 0.83 | NPC1 (0.49) | MAOBNPC1RAB9AMEN1KMT2A | |
| SCHEMBL34468752 | 0.83 | MAOB (0.60) | MAOAMAOBNPC1RAB9AMEN1 | |
| SCHEMBL21639567 | 0.82 | EGFR (0.54) | MAOANPC1RAB9AMEN1KMT2A | |
| SCHEMBL16627822 | 0.82 | MAPT (0.58) | MAOAMAOBNPC1RAB9AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260116873-A1 | APYRASE INHIBITORS | TEXAS CROP SCIENCE INC (US) | 2026-04-30 | — | — | US | claimed |
| WO-2026090571-A1 | APYRASE INHIBITORS | TEXAS CROP SCIENCE, INC. (US) | 2026-04-30 | — | — | WO | claimed |
| US-20260116873-A1 | APYRASE INHIBITORS | TEXAS CROP SCIENCE INC (US) | 2026-04-30 | — | — | US | disclosed |
| WO-2026090571-A1 | APYRASE INHIBITORS | TEXAS CROP SCIENCE, INC. (US) | 2026-04-30 | — | — | WO | disclosed |
| WO-2015050379-A1 | NOVEL QUINOLINONE DERIVATIVE AND USE THEREOF | 광주과학기술원 | 2015-04-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260116873-A1 | APYRASE INHIBITORS | APEH, AP3M1, SRR | MAOA 360/4885MAOB 372/4885AHR 117/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.